API Holdings, the parent entity of PharmEasy, on 20 August 2022, announced the withdrawal of the draft red herring prospectus (DRHP) submitted for an initial public offering (IPO). According to the media reports, the pre-IPO draft papers, which were filed on 9 November 2021, were withdrawn due to market conditions and strategic considerations. API Holdings is committed to its growth and expansion plans, and is considering to raise funds via a rights issue. The rights issue will be open for a period of 30 days. The price is expected to be Rs 100 per share and is set to open around the first week of September, reports added. API Holdings is Indias largest digital healthcare platform (based on GMV of products and services sold for the year ended 31 March 2021) which operates an integrated, end-to-end business solving the healthcare needs of consumers through technology and fulfilment capabilities. Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
